| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358264 Statine derivatives for the treatment of Alzheimer's disease |
| 04/15/2008 | US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/15/2008 | US7358260 Quinuclidine derivatives and medicinal compositions containing the same |
| 04/15/2008 | US7358257 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, antithrombotic agents |
| 04/15/2008 | US7358252 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever |
| 04/15/2008 | US7358249 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/15/2008 | US7358245 Administering a therapeutically effective amount of a compound which is a cannabinoid receptor agonist, a pharmaceutically acceptable salt of the compound, an isomer of the compound, or a pharmaceutically acceptable salt of the isomer |
| 04/15/2008 | US7358235 Nitrobenzylthioinosine compounds for relief of pain |
| 04/15/2008 | US7358233 Tetronic acid derivative |
| 04/15/2008 | US7358222 Administering a therapeutically effective amount of an epidermal growth factor receptor (EGF-R) antagonist for therapy of hypersecretion of mucus in lungs |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358066 Variants and exons of the GlyT1 transporter |
| 04/15/2008 | US7358056 Methods for modulating signal transduction mediated by TGF-β and related proteins |
| 04/15/2008 | US7357934 Intracranial botulinum toxin therapy for focal epilepsy |
| 04/15/2008 | US7357929 Placental growth factor as a target for the treatment of osteoporosis |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | CA2411468C Thrombopoietin mimetics |
| 04/15/2008 | CA2360246C Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases |
| 04/15/2008 | CA2328920C Novel derivatives of 3,3-diphenylpropylamines |
| 04/15/2008 | CA2323239C Novel matrix metalloproteinase inhibitors and down-regulators |
| 04/15/2008 | CA2269655C Peptide compositions with growth factor-like activity |
| 04/15/2008 | CA2258740C Manufacturing process for the production of purified transferrin |
| 04/15/2008 | CA2250433C Human dnase ii |
| 04/10/2008 | WO2008042970A2 Chitosan-coated calcium sulfate based medicament delivery system |
| 04/10/2008 | WO2008042024A2 Neuroactive fragments of app |
| 04/10/2008 | WO2008041767A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 04/10/2008 | WO2008041751A1 Pharmaceutical preparation for treating fibromyalgia |
| 04/10/2008 | WO2008041665A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 04/10/2008 | WO2008041514A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 04/10/2008 | WO2008041460A1 Active oxygen scavenger, activating agent and collagen production promoter each comprising cacalol |
| 04/10/2008 | WO2008040967A1 Treatment of fibrosis |
| 04/10/2008 | WO2008040153A1 Application of a coumarin compound in preparation of medicament for inducing nerve stem cell orienting differentiation |
| 04/10/2008 | WO2008020040A3 2,5-dihydroxybenzene compounds for the treatment of fibrosis |
| 04/10/2008 | WO2007149451B1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 04/10/2008 | WO2007135703A3 Patch for the treatment of the cellulite and localized adiposity |
| 04/10/2008 | US20080086000 Prostaglandin reductase |
| 04/10/2008 | US20080085995 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/10/2008 | US20080085927 Peroxisome proliferator activated receptors; dyslipidemia; anticholesterol agents; antidiabetic agents; cardiovascular disorders; gastrointestinal disorders; {4-[2-ethoxy-3-(4-trifluoromethyl-phenoxy)-propoxy]-2-methyl-phenoxy}-acetic acid |
| 04/10/2008 | US20080085919 1H-Pyrazoles Useful In Therapy |
| 04/10/2008 | US20080085918 Fitness assay and associated methods |
| 04/10/2008 | US20080085905 Pyrazine-2-carboxamide derivatives |
| 04/10/2008 | US20080085899 Tetrahydrothiopyrano pyrazole cannabinoid modulators |
| 04/10/2008 | US20080085895 Substituted Chiral Fused [1,2]Imidazo[4,5-C] Ring Compounds |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | US20080085892 Liquid dosage form of acetaminophen |
| 04/10/2008 | US20080085886 Anticancer and/or antiinflammatory activity, MEK (MAP kinase kinase) inhibitors; for example, 3-(2-Fluoro-4-iodo-phenylamino)-furo[3,2-c]pyridine-2-carboxylic acid ((R)-2,3-dihydroxy-propoxy)-amide |
| 04/10/2008 | US20080085880 crystalline forms of zotarolimus (ABT-578); bioavailability, solubility |
| 04/10/2008 | US20080085874 Small molecule potentiator of hormonal therapy for breast cancer |
| 04/10/2008 | US20080085873 Disease treatment methods |
| 04/10/2008 | US20080085869 Sense strand, antisense strand having complementarity to both the sense strand and a target gene, forming a duplex, a conjugate, facilitating cellular delivery, and a linker molecule; facilitates delivery to a cell, tissue or organism |
| 04/10/2008 | US20080085859 Drug Promoting Ceramide Transport, Base Sequence for Producing the Drug, Method of Measuring Activity of Promoting Ceramide Release and Method of Measuring Activity of Promoting Intermembrane Ceramide Transfer |
| 04/10/2008 | US20080085855 or improving the integrity of body passageways following surgery, such as at a graft site, or injury. Delivery devices including one or more therapeutic agents and a mesh are described.microtubule stabilizing agents, anti-angiogenic factors, inhibitors of smooth muscle cell growth or proliferation, |
| 04/10/2008 | US20080085852 Use of Xikvav Peptides in the Preparation of Cosmetic Compositions Which are Intented to Improve the Firmness of the Skin by Increasing Cell Adhesion |
| 04/10/2008 | US20080085330 Blueberry, carnosine, catechin, green tea extract, VitaBlue, Vitamin D3; for self-repair of injury in mammals |
| 04/10/2008 | US20080085329 Use of oxygen antagonist in vivo such as DMSO, carbon monoxide, methylmercaptan, mercaptoethanol, thiocyanate, hydrogen cyanide, or carbon disulfide; organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer |
| 04/10/2008 | US20080085320 Treating cognitive and mental conditions in adults such as attention deficit hyperactivity disorder using a polyunsaturated fatty acid (PUFA) esterified to a phosphatidylserine backbone and having improved bioavailability; no fishy smell |
| 04/10/2008 | US20080085319 Lipids containing omega-3 and omega-6 fatty acids |
| 04/10/2008 | US20080085318 Coated compositions and methods for preparing same |
| 04/10/2008 | US20080085314 Comprises controlled release acetaminophen, non-steroidal anti-inflammatory drug, and agent capable of reducing gastric acid secretion |
| 04/10/2008 | US20080085292 Composite Scaffolds Seeded with Mammalian Cells |
| 04/10/2008 | US20080085286 Mixture comprising fungal allergen for use as tool in generating polypeptides for prevention of microorganismal infection |
| 04/10/2008 | US20080085285 Use of recombinant heat shock protein complexed to kidney cancer antigen |
| 04/10/2008 | US20080085284 Construction of a Comparative Database and Identification of Virulence Factors Comparison of Polymorphic Regions in Clinical Isolates of Infectious Organisms |
| 04/10/2008 | US20080085279 Murine double mutant binding protein (MTBP) inhibitor for use as tool in treatment and prevention of cell proliferative disorders |
| 04/10/2008 | US20080085275 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 04/10/2008 | US20080085264 Targeting progenitor cells to bone marrow for prevention and treatment of cell proliferative disorders; regenerative medicine and tissue engineering |
| 04/10/2008 | US20080085262 Purified mammalian cytokines; related reagents and methods |
| 04/10/2008 | US20080085261 Vaccine Adjuvant |
| 04/10/2008 | US20080085244 comparing levels with untreated ovariectomized animal determining amount of an estrogen to reduce amyloid peptides in brain of an animal without affecting soluble APP level; administering test compound to an ovariectomized non-human animal; beta.17-estradiol reversed ovx-associated levels; Alzheimer's |
| 04/10/2008 | US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids |
| 04/10/2008 | US20080085241 highly selective; tumor-specific binding proteins; amino acid sequence; nucleic acid molecule; recombinant expression vector; host cell; cancer diagnosis; identify only those markers recognized by the human immune system as sufficiently foreign to trigger the production of antibodies; antigen is CD98hc |
| 04/10/2008 | US20080085238 to detect amyloid deposits prior to aggregation into plaques; labeled bifunctional compound binds to target protein and to chaperone protein; Alzheimer's; 1-[4-(carboxymethoxy)phenyl]-3-(3,4-dimethoxy-phenyl)-1-propanyl-1-(3,3-dimethyl-1,2-dioxopentyl)-2-piperidinecarboxylate isomers bind differently |
| 04/10/2008 | DE102006047529A1 Dermatological composition contains an oligopeptide as an agent for increasing skin sensitivity |
| 04/10/2008 | CA2664356A1 Gene/protein marker for prediction or diagnosis of pharmacological efficacy of aurora a inhibitor |
| 04/10/2008 | CA2664158A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 04/09/2008 | EP1908837A2 Human receptor proteins, related reagents and methods |
| 04/09/2008 | EP1908833A1 Novel temporal gene and application of the same |
| 04/09/2008 | EP1908823A1 Component of bromelain |
| 04/09/2008 | EP1908781A2 Modulation of immune response and methods based thereon |
| 04/09/2008 | EP1908760A1 Chromane and thiochromane-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine-beta-hydroxylase and methods of their preparation |
| 04/09/2008 | EP1908759A2 3,4-dihydro-3-amino-2H-1-benzopyrane and -benzothiopyrane derivatives as dopamine-beta-hydroxylase Inhibitors and methods of their preparation |
| 04/09/2008 | EP1908481A1 Agent for reduction of bleeding in cerebrovascular disorder |
| 04/09/2008 | EP1908474A2 Physiologically active compositions of basidiomycotina and araliaceae extracts |
| 04/09/2008 | EP1908463A2 Methods of inducing ovulation using a non-polypeptide camp level modulator |
| 04/09/2008 | EP1908462A2 Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
| 04/09/2008 | EP1907006A2 Prevention and treatment of ophthalmic complications of diabetes |
| 04/09/2008 | EP1906969A2 Methods for treating and diagnosing complications of premature birth |
| 04/09/2008 | EP1906947A1 A photosensitising composition and uses thereof |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1429757B1 Crystalline forms of fluvastatin sodium |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | EP1360311B1 Membrane penetrating peptides and uses thereof |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP1124551B1 Delta 9 tetrahydrocannabinol (delta 9 thc) solution metered dose inhalers and methods of use |
| 04/09/2008 | EP1082112B1 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 04/09/2008 | EP1058725B1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 04/09/2008 | EP1036175B1 Human brain derived kcnq2 potassium channel |
| 04/09/2008 | EP0972028B1 Mutants of vascular endothelial growth factor c (vegf-c) and uses thereof |